This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Access the science, technology and contacts that you need to accelerate your biologics and novel products towards commercial success.

I AM BIO Podcast: Accelerating Hope - The Pathway for Cures

Share this article

When people were dying from AIDS in the 1980s and 90s, Congress found a way to expedite the drug approval process and saved countless lives. Established in 1992, the Accelerated Approval Program allows the FDA to speed approval of drugs for patients with serious and life-threatening conditions.

The Latest Episode:

  • John Crowley, Executive Chairman, Amicus Therapeutics
  • Emil D. Kakkis, CEO and President, Ultragenyx
  • Cartier Esham, Chief Scientific Officer, BIO
  • Duane Schulthess, CEO, Vital Transformation

In this episode we talk with the father of children with a rare disease, a company CEO working to treat rare diseases and two policy experts on Accelerated Approval.

Click below to listen:

Share this article

Upcoming event

BioProcess International Europe

09 - 12 Apr 2024, Messe Wien Congress Centre, Vienna

Europe’s Leading BioProcessing Event for Accelerating Next Generation mAbs, Novel Modalities and ATMPs to Commercial Success

Go to site